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INTRODUCTION
Thyrotropin-releasing hormone (TRH), produced 
in the hypothalamus, is the major stimulator of 
thyroid-stimulating hormone (TSH) synthesis and 
release from the anterior lobe of the pituitary. This 
exerts a positive input to the thyroid hormones 
(TH), thyroxine (T4) and biologically active tri-
iodothyronine (T3). By negative feedback at the 
hypothalamic and pituitary level, TH are the most 
important physiological regulators of the serum 
TSH level (M i t s u m a  et al., 1990).  
During fetal development of the rat pituitary 
gland, TSH-immunoreactive cells first appear in 
the pars tuberalis, but their proliferation and dif-
ferentiation are not controlled by the transcriptional 
factor Pit-1 (S a k a i  et al., 1999). In the rat fetal 
pars distalis, TSH mRNA was detected on day 15 
of gestation (B r o w n  et al.,  2000); thereafter the 
thyrotrophs, immunocytochemically recognized in 
16.5-17.5-day-old fetuses, were under the determi-
nant role of Pit-1 (S a k a i  et al., 1999). However, 
thyrotrophs were few in 17.5-day-old rat fetuses, a 
rapid increase occurring during the second week 
after birth (Ta n i g u c h i  et al., 2001).  
Secretion TSH into fetal circulation first occurs 
on days 17-18, causing an immediate increase in 
TSH receptor mRNA in the thyroid. Acting through 
its specific receptor, TSH plays an important role in 
thyroid gland differentiation, growth, and function 
(B r o w n  et al., 2000). Functioning of the pituitary-
thyroid axis before birth is of critical importance, as 
thyroid hormones are essential for many aspects of 
fetal development, growth, and cellular metabolism 
(M o r r e a l e  d e  E s c o b a r  et al., 1993; S i l v a , 
1995). Thus, thyroid hormones are involved in the 
regulation of normal CNS maturation processes 
such as neurogenesis, neural cell migration, den-
dritic and axon growth, synaptogenesis, gliogen-
esis, myelination, and neurotransmitter synthesis 
(A l v a r e z - D o l a d o  et al., 2000; B a n s a l  et al., 
2005); gonadal development (F r a n c a v i l a  et al., 
1991); and respiratory enzyme synthesis and heat 
production (B h a r g a v a  et al., 2007).  
Glucocorticoids also exert powerful influence 
on the intrauterine development of fetal organ sys-
tems. Glucocorticoid receptors are found intracel-
lularly in almost all tissues (K i t r a k i  et al., 1997). 
Glucocorticoids affect fetal brain development, lung 
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maturity and surfactant phosphatidylcholine syn-
thesis, induction of glucogenic hepatic enzymes, 
and maturation of rat renal mitochondria, providing 
effective oxidative phosphorylation (B a r k e r ,  1995; 
P r i e u r  et al., 1998; D e  K l o e t ,  2004). These 
actions ensure an adequate response to environmen-
tal stimuli and maintenance of homeostasis in the 
newborns. Steroid administration during pregnancy 
and in premature infants therefore became the stan-
dard way to prevent life-threatening complications 
such as respiratory distress syndrome (F i t z e r a l d 
et al., 1998). 
The aim of our study was to investigate the influ-
ence of maternal treatment with the synthetic glu-
cocorticoid dexamethasone (Dx) during the period 
of gestation when the fetal pituitary-thyroid axis is 
establishing its function on some histological and 
morphometric characteristics of pituitary TSH cells 
in 19-day-old fetuses. 
MATERIALS AND METHODS
Animals
Female and male Wistar strain rats, weighing approx-
imately 250 and 400 g, respectively, were mated in the 
laboratory at the Institute for Biological Research, 
Belgrade, during the night. The morning on which 
sperm positive smears were obtained was declared 
gestation day 1. Pregnant females were housed indi-
vidually under standard conditions (12:12 h light-
dark cycle at 22 ± 2°C) and offered food and water 
ad libitum. Dams were randomized into two groups: 
a control and an experimental group, each consist-
ing of six animals. On day 16 of pregnancy, the 
experimental dams received subcutaneously 1.0 mg 
Dx (dexamethasone phosphate - Krka, Novo Mesto, 
Slovenia, dissolved in 0.9% saline)/kg b.w., followed 
by 0.5 mg Dx/kg b.w./day on days 17 and 18 of ges-
tation. The control gravid females received the same 
volume of saline vehicle. On day 19 of gestation, the 
females were sacrificed under ether narcosis and the 
fetuses were removed and prepared for histological 
and morphometric measurements. Experimental 
protocols were approved by the local Animal Care 
Committee and conformed to the recommendations 
given in "Guide for the Care and Use of Laboratory 
Animals" (National Academy Press, Washington 
D.C., 1996).
Tissue preparation
The pituitary glands, with part of the sphenoid bone 
or fetal heads, were excised and fixed in Bouin's 
solution for 48 h and embedded in paraffin. Serial 5-
µm-thick tissue sections were deparaffinized in xylol 
and decreasing series of ethanol. Three pituitary 
sections from the dorsal, medial, and ventral parts 
were prepared for immunocytochemical staining. 
Pituitary TSHβ was localized immunocytochemical-
ly using the peroxidase-anti-peroxidase (PAP) com-
plex method of Sternberger et al. (1970). Primary 
rabbit anti-rat TSHβ antiserum was kindly provided 
by Dr. A.F. Parlow, NIH, Bethesda, MD, USA. 
Morphometrical and stereological measurements
All stereological analyses were carried out using a 
workstation comprising a microscope (Olympus, BX-
51) equipped with a CCD video camera (PixeLink) 
connected to a 19” PC monitor (Dell). The whole 
system was controlled by the newCAST stereologi-
cal software package (VIS – Visiopharm Integrator 
System, version 2.12.1.0, Visiopharm, Denmark). 
The main objectives used were planachromatic 4x 
and 20x dry lenses. 
Firstly, the number of cells per unit of area was 
determined. At the monitor, a final magnification 
of 150x allowed easy and accurate recognition of 
tissue boundaries. After defining adenohypophyseal 
boundaries on the examined pituitary sections, the 
area in μm2 was determined automatically using the 
Mask tool of newCAST software. Then exact count-
ing of TSHβ immunostained cells was carried out at 
a final magnification of 750x (at the monitor) and 
the number of cells was expressed per unit of area.   
Volume density was estimated employing a point 
grid with 16 points. After defining adenohypophy-
seal boundaries, the whole structure was overlaid 
with the point grid. The number of points falling 
within immunolabeled TSH cells divided by the 
total number of points hitting the reference space, 
i.e., marked adenohypophyseal tissue, represents the 
volume density of TSH cells.
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Fig. 1. A. Pituitary gland of 19-day-old fetuses with numerous im-
munocytochemically labeled TSH cells in the pars distalis (pd) lo-
cated around a capillary and among other cells B. After maternal Dx 
administration, a decrease in the number of immunocytochemically 
labeled fetal TSH cells is evident. Abbreviations: pd) pars distalis; →) 
immunocytochemically labeled TSH cells; bar = 20 μm.
The Rotator tool was used for estimation of the 
cell volume of 150-200 cells with nuclei per animal.  
Digital images were made on a Leica DM RB Photo 
Microscope (Leica, Wetzlar, Germany) with a JVC TK 
1280E Video Camera (Leica) using the Qwin program 
(Leica) for acquisition and analysis of images.
Statistical analysis
All results are expressed as means for six animals 
per group ± SD. Data were tested for normality 
of distribution by the Kolmogorov–Smirnov test, 
whereas the homogeneity of variances was evaluated 
by Leven’s test. Student’s t-test was used to compare 
mean values. The minimum level of statistical sig-
nificance was set at p<0.05.
RESULTS  
Histological analysis
The presence of TSH cells was detected in the 
pituitary pars distalis in 19-day-old control fetuses. 
These cells were characterized by large rounded 
or elongated nuclei surrounded by cytoplasm, the 
immunopositivity of which varied from intensive 
to pale. Immunocytochemically labeled TSH cells 
exhibited different shapes, rounded or polygonal, 
while cytoplasmic processes were occasionally pres-
ent (Fig. 1). They were uniformly distributed among 
the parenchymal cells and around the capillary 
network. Groups of two to three cells were seen 
on histological sections rarely. After maternal Dx 
administration the histological appearance of fetal 
TSH cells was not altered significantly in relation to 
the controls, considering cell immunopositivity and 
size (Fig. 1). 
 Morphometric and stereological analysis 
The volume of TSH cells in 19-day-old fetuses was 
not significantly changed after Dx treatment of preg-
nant rats. Administration of Dx to rats during the 
last week of pregnancy led to a significant decrease 
of TSH cell number per unit of area (p<0.05) in 
19-day-old fetuses in comparison with the control 
group. Also, maternal Dx application induced a 
significant decline of fetal TSH cell volume density 
(p<0.05) compared to the controls (Fig. 2).
A
B
DISCUSSION
The results presented here indicate that fetal expo-
sure to excess glucocorticoid levels in utero leads to 
a decreased number of fetal pituitary TSH cells per 
unit of area and a decline in their volume density 
in 19-day-old fetuses. The gravid female rats were 
treated with Dx from days 16 to 18 of pregnancy, 
a period when all types of fetal pituitary hormone-
producing cells start to function.  
Access of maternal endogenous glucocorticoids 
(corticosterone in rats) to the fetus is limited owing 
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Fig. 2. Morphometric parameters for 19-day-old fetal TSH cells after 
maternal treatment with Dx (Dx, experimental group) or saline (C, 
control group). A. Volume of TSH cells. B. Number of TSH cells per 
unit of area. C. Volume density of TSH cells. Results are presented as 
means ± S.D. (n = 6); * p <0.05 vs. C.
to the activity of placental 11β-hydroxysteroid-dehy-
drogenase type 2 (11βHSD2), which oxidizes active 
corticosteroids to inactive ketone products. The 
synthetic glucocorticoid Dx is not metabolized by 
placental 11βHSD2, so it enters the fetal circulation 
and can influence many aspects of fetal development 
(S e c k l ,  2001).
During pituitary gland development, the num-
ber of TSH cells increases as a consequence of 
precursor cell differentiation and further division 
of already existing TSH cells. Ta n i g u c h i  et al. 
(2001) demonstrated the proliferation of differen-
tiated thyrotrophs in fetal rats by double immu-
nostaining with ant-BrdU and anti-rTSH. They 
concluded that this proliferation occurred during 
the late fetal period. Our results showed that the 
number of fetal TSH cells is under the influence of 
Dx, too. The decreased number of TSH cells per 
unit of area and lower volume density of TSH cells 
in 19-day-old fetuses indicated that, after passing 
through the feto-placental barrier, Dx inhibited 
the proliferation of both precursors committed to a 
TSH destiny and differentiated TSH cells entering 
mitosis. It is known that during fetal development 
Dx also exerts strong antiproliferative action on dif-
ferent cell types, such as neurons in the developing 
brain (M a t t h e w s , 2000), pituitary ACTH cells 
(M a n o j l o v i ć - S t o j a n o s k i  et al., 2006), and 
insulin-producing cells (S h e i n  et al., 2003), as 
well as causing overall fetal growth impairment in 
humans, rats, and sheep (J o b e  et al., 1998).
Using triple immunofluorescent staining for the 
α glycoprotein subunit βTSH and proliferate marker 
PCNA, P o p e  et al. (2006) also showed that dif-
ferentiated TSH cells retained the ability to divide 
in human and mouse fetuses. This is probably the 
reason why the antiproliferative action of Dx on fetal 
TSH cells becomes pronounced and measurable. On 
the contrary, the same authors demonstrated that 
differentiated gonadotrophs were non-dividing cells 
during the fetal period. 
Induction of programmed cell death by glu-
cocorticoid treatment might also contribute to the 
decrease in number of TSH cells and their volume 
density that was established 24 h after maternal 
A
B
C
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exposure to Dx in our experimental conditions. 
Exposure to Dx induced a short burst of apoptosis 
that began a day or two after the start of treatment 
and lasted for 24 h or less in rat male adult pituitary 
glands (N o l a n  et al., 2004). Apoptosis increased 
in precursors, i.e., in hormonally undifferentiated 
pituitary cells, after Dx application (N o l a n  and 
L e v y,  2006).
We found that exposure to Dx in utero did not 
influence cell volume or immunostaining intensity 
of TSH cells in 19-day-old fetuses, indicating that 
hormone synthesis and release were not affected by 
the treatment. 
Repeated courses of maternal glucocorticoid 
therapy were approved and have become standard 
practice in cases of preterm delivery to minimize 
the frequency of respiratory problems and perinatal 
death. Investigations using animal models and clini-
cal practice are focused on the short- and long-term 
consequences of such treatment (B a k k e r  et al., 
2001; K a p o o r  et al., 2008). The programming 
concept implied that changes caused by alterations 
to the intrauterine environment, e.g., fetal exposure 
to excess glucocorticoid, might be a basis for suscep-
tibility to later chronic diseases (B a r k e r ,  1995). 
Further investigations are necessary to establish 
whether the decrease of TSH cell number in 19-day-
old fetuses found here influences developmental 
processes with later long-term consequences or is 
reversed by fetal homeostatic mechanisms allowing 
normal functioning of the pituitary-thyroid axis.  
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ТРеТМАН ДеКСАМеТАЗОНОМ ТОКОМ ГРАВИДИТеТА
УТИЧе НА БРОЈ TSH ЋеЛИЈА КОД ФеТУСА ПАЦОВА
МИЛИЦА МАНОЈЛОВИЋ-СТОЈАНОСКИ, НАТАША НЕСТОРОВИЋ, НАТАША НЕГИЋ,
БРАНКА ШОШИЋ-ЈУРЈЕВИЋ, СВЕТЛАНА ТРИФУНОВИЋ, ВЕРИЦА МИЛОШЕВИЋ и МИЛКА СЕКУЛИЋ4
Институт за биолошка истраживања”Синиша Станковић”, 11060 Београд, Србија
Глу­кокортикоиди и тироидни хормони контро-
лишу­ бројне аспекте раз­воја фету­са. Користећи 
иму­ноцитохемију­ и стереолошке методе испитива-
ли смо ефекте примене дексаметаз­она (Dks) током 
гестације на TSH ћелије хипофиз­е фету­са пацова 
старих 19 дана. Доз­е од 1.0, 0.5 и 0.5 мг Dks/кг тм/
дан примењиване су­ гравидним женкама три у­з­а-
стопна дана, почев од 16. дана гестације. Третман 
Dks код гравидних женки у­з­року­је з­начајно смање-
ње броја TSH ћелија фету­са по јединици површине 
и њихове волу­менске гу­стине у­ поређењу­ са одгова-
рају­ћим контролама. Наши рез­у­лтати показ­у­ју­ да 
матернална примена Dks инхибира му­лтипликаци-
ју­ TSH ћелија код фету­са старих 19 дана.
